← Back to Search

Modified Diabetes Prevention Program for Obesity, Weight Loss, and Prediabetes (DPP-TOO Trial)

N/A
Waitlist Available
Led By Courtney E Gamston, PharmD
Research Sponsored by Auburn University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

DPP-TOO Trial Summary

This trial hopes to show that community pharmacies can help with weight loss and diabetes prevention, improving health outcomes.

Eligible Conditions
  • Prediabetes
  • Weight Loss

DPP-TOO Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in A1c
Weight loss
Secondary outcome measures
Blood pressure change
Physical activity change
Proportion of patients meeting DPP program criteria
Other outcome measures
Change in Processes of Change for Weight Loss including the following processes: emotional re-evaluation, weight consequences evaluation, supporting relationships, and weight management actions
Change in Stage of Change for Weight Loss
Change in level of confidence in ability to motivate oneself to maintain dietary and physical activity behaviors for at least 6 months
+2 more

DPP-TOO Trial Design

1Treatment groups
Experimental Treatment
Group I: Modified DPPExperimental Treatment1 Intervention
Participants in this arm will participate in the modified Diabetes Prevention Program curriculum.

Find a Location

Who is running the clinical trial?

Auburn UniversityLead Sponsor
71 Previous Clinical Trials
14,310 Total Patients Enrolled
Courtney E Gamston, PharmDPrincipal InvestigatorAuburn University Harrison School of Pharmacy

Media Library

Modified Diabetes Prevention Program Curriculum Clinical Trial Eligibility Overview. Trial Name: NCT05640869 — N/A
Prediabetes Research Study Groups: Modified DPP
Prediabetes Clinical Trial 2023: Modified Diabetes Prevention Program Curriculum Highlights & Side Effects. Trial Name: NCT05640869 — N/A
Modified Diabetes Prevention Program Curriculum 2023 Treatment Timeline for Medical Study. Trial Name: NCT05640869 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment still available for this research trial?

"As per the records on clinicaltrials.gov, this trial is not currently accepting any more participants; it was initially posted on December 15th 2022 and received its last update November 28th of the same year. Nonetheless, there are 587 other trials that one can apply for at this time."

Answered by AI

Who else is applying?

What site did they apply to?
Auburn University
What portion of applicants met pre-screening criteria?
Met criteria

Why did patients apply to this trial?

Need to control my blood sugar And I need to lose weight because I want to be healthy.
PatientReceived 2+ prior treatments
~24 spots leftby Mar 2025